Interleukin-17 contributes to the pathogenesis of autoimmune hepatitis through inducing hepatic interleukin-6 expression

PLoS ONE

Volumn 6, Issue 4, 2011, Pages

  Zhao, Li ^a   Tang, Yanli ^a   You, Zhengrui ^a   Wang, Qixia ^a   Liang, Shuwen ^b   Han, Xiaofeng ^a   Qiu, Dekai ^a   Wei, Jue ^a   Liu, Yuan ^a   Shen, Lei ^a   Chen, Xiaoyu ^a   Peng, Yanshen ^a   Li, Zhiping ^b   Ma, Xiong ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 23; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE; RETINOID RELATED ORPHAN RECEPTOR GAMMA; RETINOID RELATED ORPHAN RECEPTOR GAMMA T; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG; IL17A PROTEIN, HUMAN;

ADULT; ARTICLE; AUTOIMMUNE HEPATITIS; CELL STRAIN HEPG2; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HEPATITIS B; HUMAN; HUMAN CELL; HUMAN TISSUE; INTERLEUKIN 17 BLOOD LEVEL; INTERLEUKIN 23 BLOOD LEVEL; LIVER BIOPSY; LIVER CELL; MALE; PATHOGENESIS; POSITIVE FEEDBACK; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TH17 CELL; ADOLESCENT; BIOPSY; BLOOD; CASE CONTROL STUDY; DRUG EFFECT; ENZYMOLOGY; IMMUNOLOGY; LIVER; METABOLISM; MIDDLE AGED; PATHOLOGY; SECRETION;

ADOLESCENT; ADULT; BIOPSY; CASE-CONTROL STUDIES; FEMALE; HEP G2 CELLS; HEPATITIS B, CHRONIC; HEPATITIS, AUTOIMMUNE; HUMANS; INTERLEUKIN-17; INTERLEUKIN-23; INTERLEUKIN-6; LIVER; MALE; MAP KINASE SIGNALING SYSTEM; MIDDLE AGED; MITOGEN-ACTIVATED PROTEIN KINASES; TH17 CELLS; YOUNG ADULT;

EID: 79955416252     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0018909     Document Type: Article

References (31)

1. Krawitt EL, (2006) Autoimmune hepatitis. N Engl J Med 354: 54-66.
2. Czaja AJ, Freese DK, (2002) Diagnosis and treatment of autoimmune hepatitis. Hepatology 36: 479-97.
3. Vergani D, Mieli-Vergani G, (2007) The impact of autoimmunity on hepatocytes. Semin Liver Dis 27: 140-51.
4. Senaldi G, Portmann B, Mowat AP, Mieli-Vergani G, Vergani D, (1992) Immunohistochemical features of the portal tract mononuclear cell infiltrate in chronic aggressive hepatitis. Arch Dis Child 67: 1447-53.
5. Bertolino P, (2008) Interleukin-22, interleukin-17, and other cytokines: a wall is coming down. Hepatology 47: 345-8.
6. Longhi MS, Ma Y, Bogdanos DP, Cheeseman P, Mieli-Vergani G, et al. (2004) Impairment of CD4(+)CD25(+) regulatory T-cells in autoimmune liver disease. J Hepatol 41: 31-7.
7. Longhi MS, Hussain MJ, Mitry RR, Arora SK, Mieli-Vergani G, et al. (2006) Functional study of CD4+CD25+ regulatory T cells in health and autoimmune hepatitis. J Immunol 176: 4484-91.
8. Bettelli E, Korn T, Oukka M, Kuchroo VK, (2008) Induction and effector functions of T(H)17 cells. Nature 453: 1051-7.
9. Bettelli E, Carrier Y, Gao W, Korn T, Strom TB, et al. (2006) Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441: 235-8.
10. Lan RY, Salunga TL, Tsuneyama K, Lian ZX, Yang GX, et al. (2009) Hepatic IL-17 responses in human and murine primary biliary cirrhosis. J Autoimmun 32: 43-51.
11. Lemmers A, Moreno C, Gustot T, Marechal R, Degre D, et al. (2009) The interleukin-17 pathway is involved in human alcoholic liver disease. Hepatology 49: 646-57.
12. Lafdil F, Wang H, Park O, Zhang W, Moritoki Y, et al. (2009) Myeloid STAT3 inhibits T cell-mediated hepatitis by regulating T helper 1 cytokine and interleukin-17 production. Gastroenterology: 137: 2125-35 e1-2.
13. Acosta-Rodriguez EV, Rivino L, Geginat J, Jarrossay D, Gattorno M, et al. (2007) Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells. Nat Immunol 8: 639-46.
14. Korn T, Bettelli E, Oukka M, Kuchroo VK, (2009) IL-17 and Th17 Cells. Annu Rev Immunol 27: 485-517.
15. Zhou L, Ivanov II, Spolski R, Min R, Shenderov K, et al. (2007) IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nat Immunol 8: 967-74.
16. Ogura H, Murakami M, Okuyama Y, Tsuruoka M, Kitabayashi C, et al. (2008) Interleukin-17 promotes autoimmunity by triggering a positive-feedback loop via interleukin-6 induction. Immunity 29: 628-36.
17. Streetz KL, Luedde T, Manns MP, Trautwein C, (2000) Interleukin 6 and liver regeneration. Gut 47: 309-12.
18. Dai J, Huang C, Wu J, Yang C, Frenkel K, et al. (2004) Iron-induced interleukin-6 gene expression: possible mediation through the extracellular signal-regulated kinase and p38 mitogen-activated protein kinase pathways. Toxicology 203: 199-209.
19. Patel DN, King CA, Bailey SR, Holt JW, Venkatachalam K, et al. (2007) Interleukin-17 stimulates C-reactive protein expression in hepatocytes and smooth muscle cells via p38 MAPK and ERK1/2-dependent NF-kappaB and C/EBPbeta activation. J Biol Chem 282: 27229-38.
20. Kanda H, Tateya S, Tamori Y, Kotani K, Hiasa K, et al. (2006) MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. J Clin Invest 116: 1494-505.
21. Fisher NC, Neil DA, Williams A, Adams DH, (1999) Serum concentrations and peripheral secretion of the beta chemokines monocyte chemoattractant protein 1 and macrophage inflammatory protein 1alpha in alcoholic liver disease. Gut 45: 416-20.
22. Lan RY, Salunga TL, Tsuneyama K, Lian ZX, Yang GX, et al. (2009) Hepatic IL-17 responses in human and murine primary biliary cirrhosis. J Autoimmun 32: 43-51.
23. Zhang JY, Zhang Z, Lin F, Zou ZS, Xu RN, et al. (2009) Interleukin-17-producing CD4(+) T cells increase with severity of liver damage in patients with chronic hepatitis B. Hepatology 51: 81-91.
24. Nakae S, Komiyama Y, Nambu A, Sudo K, Iwase M, et al. (2002) Antigen-specific T cell sensitization is impaired in IL-17-deficient mice, causing suppression of allergic cellular and humoral responses. Immunity 17: 375-87.
25. Nakae S, Nambu A, Sudo K, Iwakura Y, (2003) Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice. J Immunol 171: 6173-7.
26. Chabaud M, Durand JM, Buchs N, Fossiez F, Page G, et al. (1999) Human interleukin-17: A T cell-derived proinflammatory cytokine produced by the rheumatoid synovium. Arthritis Rheum 42: 963-70.
27. Fujino S, Andoh A, Bamba S, Ogawa A, Hata K, et al. (2003) Increased expression of interleukin 17 in inflammatory bowel disease. Gut 52: 65-70.
28. Wong CK, Ho CY, Li EK, Lam CW, (2000) Elevation of proinflammatory cytokine (IL-18, IL-17, IL-12) and Th2 cytokine (IL-4) concentrations in patients with systemic lupus erythematosus. Lupus 9: 589-93.
29. Jiang S, Lechler RI, (2003) Regulatory T cells in the control of transplantation tolerance and autoimmunity. Am J Transplant 3: 516-24.
30. Longhi MS, Meda F, Wang P, Samyn M, Mieli-Vergani G, et al. (2008) Expansion and de novo generation of potentially therapeutic regulatory T cells in patients with autoimmune hepatitis. Hepatology 47: 581-91.
31. Hori S, Nomura T, Sakaguchi S, (2003) Control of Regulatory T Cell Development by the Transcription Factor Foxp3. Science 299: 1057-1061.